Neupane et al.31 identified MeCP2 as a frequently amplified oncogene in several cancer types, including breast cancer, cervical cancer, lung cancer and uterine cancer, and they reported the ability of MeCP2 to drive breast cancer development. Here, MECP2 is linked to cervical cancer.